News and Trends 22 Jul 2022
InterVenn expands globally to drive the potential of glycoproteomics to improve patient outcomes
Intervenn Biosciences is expanding across Asia-Pacific and North America and opening new facilities in Kuala Lumpur, the Philippines, Australia and California. The company leverages glycoporteomics and says it is adding…